Zeo ScientifiX ZEOX
OTC ZEOX
$1.16 -0.04 (-3.33%)
At close: Sep 8, 2026 · 4:00 PM EDT

Zeo ScientifiX (ZEOX) Non Operating Interest Expenses (2014 - 2026)

Zeo ScientifiX (ZEOX) posted Non Operating Interest Expenses of $11000.0 for Q2 2026, up 10.0% on a QoQ basis from $10000.0 in Q1 2026, and down 47.62% year-over-year from $21000.0 in Q2 2025.

Analysis

Zeo ScientifiX (ZEOX) Non Operating Interest Expenses (2014 - 2026) Analysis & Trends

Zeo ScientifiX has reported Non Operating Interest Expenses for 11 years, with the latest figure at $11000.0 in Q2 2026.

  • On a quarterly basis, Non Operating Interest Expenses fell 47.62% year-over-year to $11000.0 in Q2 2026; TTM through Apr 2026 was $76000.0, a 13.64% decrease from a year earlier, with the FY2025 full-year figure at $98000.0, up 6.52% from the prior year.
  • Non Operating Interest Expenses was $11000.0 for Q2 2026 at Zeo ScientifiX, up from $10000.0 in the prior quarter.
  • The five-year high for Non Operating Interest Expenses was $172000.0 in Q3 2023, with the low at $10000.0 in Q1 2026.
  • Average Non Operating Interest Expenses over 5 years is $57847.8, with a median of $29500.0 recorded in 2024.
  • The sharpest annual moves came in 2022 and 2024: Non Operating Interest Expenses soared 2349.8% in 2022, then plunged 86.63% in 2024.
  • Over 5 years, Non Operating Interest Expenses stood at $75066.0 in 2022, then rose by 19.89% to $90000.0 in 2023, then plunged by 75.56% to $22000.0 in 2024, then soared by 45.45% to $32000.0 in 2025, then tumbled by 65.62% to $11000.0 in 2026.
  • The last three Non Operating Interest Expenses figures came in at $11000.0 (Q2 2026), $10000.0 (Q1 2026), and $32000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - -
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn 4.00 Bn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn -5.80 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 14.37 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - -
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 2.95 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn -
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 160,000.00
10 Zeo ScientifiX 8.53 Mn 6.69 Mn 2.06 Mn 11,000.00
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 11,000.00
Jan 31, 2026 10,000.00
Oct 31, 2025 32,000.00
Jul 31, 2025 23,000.00
Apr 30, 2025 21,000.00
Jan 31, 2025 22,000.00
Oct 31, 2024 22,000.00
Jul 31, 2024 23,000.00
Apr 30, 2024 20,000.00
Jan 31, 2024 27,000.00
Oct 31, 2023 90,000.00
Jul 31, 2023 172,000.00
Apr 30, 2023 109,000.00
Jan 31, 2023 61,000.00
Oct 31, 2022 75,066.00
Jul 31, 2022 133,648.00
Apr 30, 2022 149,242.00
Jan 31, 2022 40,304.00
Oct 31, 2021 6,151.00
Jul 31, 2021 19,473.00